Canada markets close in 5 hours 2 minutes

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.9100-0.0100 (-0.52%)
As of 10:58AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 522.92M
Enterprise Value 892.38M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)2.50
Price/Book (mrq)0.81
Enterprise Value/Revenue 4.45
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.98
52-Week Change 3-84.71%
S&P500 52-Week Change 328.04%
52 Week High 314.5500
52 Week Low 31.2500
50-Day Moving Average 32.6706
200-Day Moving Average 36.8475

Share Statistics

Avg Vol (3 month) 310.92M
Avg Vol (10 day) 312.57M
Shares Outstanding 5272.36M
Implied Shares Outstanding 6272.36M
Float 8270.9M
% Held by Insiders 11.85%
% Held by Institutions 194.56%
Shares Short (Apr 30, 2024) 452.82M
Short Ratio (Apr 30, 2024) 44.17
Short % of Float (Apr 30, 2024) 422.34%
Short % of Shares Outstanding (Apr 30, 2024) 419.39%
Shares Short (prior month Mar 28, 2024) 449.05M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin -148.13%
Operating Margin (ttm)-209.82%

Management Effectiveness

Return on Assets (ttm)-10.84%
Return on Equity (ttm)-44.28%

Income Statement

Revenue (ttm)200.43M
Revenue Per Share (ttm)0.77
Quarterly Revenue Growth (yoy)-0.20%
Gross Profit (ttm)N/A
EBITDA -282.54M
Net Income Avi to Common (ttm)-296.9M
Diluted EPS (ttm)-1.1400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)561.91M
Total Cash Per Share (mrq)2.06
Total Debt (mrq)931.37M
Total Debt/Equity (mrq)143.50%
Current Ratio (mrq)9.28
Book Value Per Share (mrq)2.38

Cash Flow Statement

Operating Cash Flow (ttm)-240.16M
Levered Free Cash Flow (ttm)-304.23M